Dragana Lovre

723 total citations
17 papers, 265 citations indexed

About

Dragana Lovre is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Dragana Lovre has authored 17 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Dragana Lovre's work include Menopause: Health Impacts and Treatments (6 papers), Estrogen and related hormone effects (4 papers) and COVID-19 Clinical Research Studies (3 papers). Dragana Lovre is often cited by papers focused on Menopause: Health Impacts and Treatments (6 papers), Estrogen and related hormone effects (4 papers) and COVID-19 Clinical Research Studies (3 papers). Dragana Lovre collaborates with scholars based in United States and France. Dragana Lovre's co-authors include Franck Mauvais‐Jarvis, Vivian Fonseca, Beibei Xu, Sarah H. Lindsey, Kara L. Marlatt, Timothy D. Allerton, Joshua L. Denson, Ryan M. Hulteen, Yuanhao Zu and Yilin Yoshida and has published in prestigious journals such as Diabetes, European Journal of Endocrinology and Biochimie.

In The Last Decade

Dragana Lovre

12 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dragana Lovre United States	10	110	58	50	39	38	17	265
Rachel Njeim Lebanon	9	49 0.4×	69 1.2×	34 0.7×	19 0.5×	41 1.1×	19	261
Coimbatore Subramanian Shanthi Rani India	9	203 1.8×	43 0.7×	68 1.4×	47 1.2×	16 0.4×	15	384
Assefa Agegnehu Teshome Ethiopia	8	58 0.5×	79 1.4×	18 0.4×	25 0.6×	14 0.4×	28	316
Hun Jee Choe South Korea	7	86 0.8×	28 0.5×	20 0.4×	54 1.4×	20 0.5×	26	236
SUBHASH KUMAR WANGNOO India	8	132 1.2×	34 0.6×	22 0.4×	10 0.3×	28 0.7×	38	233
Sunil Nayak India	9	177 1.6×	76 1.3×	48 1.0×	20 0.5×	25 0.7×	28	372
Aman Rajpal United States	9	144 1.3×	53 0.9×	57 1.1×	75 1.9×	82 2.2×	20	390
Sergio Jansen‐Chaparro Spain	9	179 1.6×	42 0.7×	67 1.3×	52 1.3×	16 0.4×	13	332
Areti Papadopoulou United Kingdom	5	40 0.4×	40 0.7×	46 0.9×	45 1.2×	8 0.2×	7	241
Jing Cheng China	11	182 1.7×	63 1.1×	60 1.2×	67 1.7×	10 0.3×	25	316

Countries citing papers authored by Dragana Lovre

Since Specialization

Citations

This map shows the geographic impact of Dragana Lovre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dragana Lovre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dragana Lovre more than expected).

Fields of papers citing papers by Dragana Lovre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dragana Lovre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dragana Lovre. The network helps show where Dragana Lovre may publish in the future.

Co-authorship network of co-authors of Dragana Lovre

This figure shows the co-authorship network connecting the top 25 collaborators of Dragana Lovre. A scholar is included among the top collaborators of Dragana Lovre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dragana Lovre. Dragana Lovre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nasser, Samar A., Dragana Lovre, Farbod Zahedi Tajrishi, & Keith C. Ferdinand. (2025). Overcoming underutilization of continuous glucose monitoring devices with diabetes among disparate populations. Endocrine Research. 51(1). 15–26.

Williams, Tyler D., et al.. (2024). 12343 Cardiac Function Recovery Following Left Adrenalectomy For A Pheochromocytoma With Ectopic ACTH Syndrome. Journal of the Endocrine Society. 8(Supplement_1).

Hulteen, Ryan M., Kara L. Marlatt, Timothy D. Allerton, & Dragana Lovre. (2023). Detrimental Changes in Health during Menopause: The Role of Physical Activity. International Journal of Sports Medicine. 44(6). 389–396. 16 indexed citations

Yoshida, Yilin, Yuanhao Zu, Dragana Lovre, et al.. (2022). Sex differences in determinants of COVID-19 severe outcomes – findings from the National COVID Cohort Collaborative (N3C). BMC Infectious Diseases. 22(1). 784–784. 7 indexed citations

Lovre, Dragana, et al.. (2022). 194-LB: Tacrolimus-Induced Hyperglycemic Emergencies in Posttransplant Patients—A Case Series. Diabetes. 71(Supplement_1).

Wilson, Samuel H., et al.. (2022). PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH. Journal of the Endocrine Society. 6(Supplement_1). A538–A539.

Lovre, Dragana, et al.. (2021). Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial. BMJ Open. 11(11). e053684–e053684. 17 indexed citations

Yoshida, Yilin, Yuanhao Zu, Sarah M. Wilson, et al.. (2021). Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans. Biology of Sex Differences. 12(1). 20–20. 29 indexed citations

Lovre, Dragana, et al.. (2020). SAT-272 Pituitary Macroadenoma Co-Secreting TSH and PRL Responsive to Cabergoline. Journal of the Endocrine Society. 4(Supplement_1).

10.

Marlatt, Kara L., Dragana Lovre, Robbie A. Beyl, et al.. (2020). Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women. European Journal of Endocrinology. 183(4). 439–452. 15 indexed citations

11.

Lovre, Dragana, Erin Peacock, Cynthia Moreau, et al.. (2019). Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women. Journal of the Endocrine Society. 3(8). 1583–1594. 9 indexed citations

12.

Lovre, Dragana, et al.. (2017). Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients. Endocrinology and Metabolism Clinics of North America. 47(1). 237–257. 33 indexed citations

13.

Xu, Beibei, Dragana Lovre, & Franck Mauvais‐Jarvis. (2017). The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights. Journal of Diabetes and its Complications. 31(4). 773–779. 28 indexed citations

14.

Lovre, Dragana, Sarah H. Lindsey, & Franck Mauvais‐Jarvis. (2016). Effect of menopausal hormone therapy on components of the metabolic syndrome. Therapeutic Advances in Cardiovascular Disease. 11(1). 33–43. 30 indexed citations

15.

Lovre, Dragana, et al.. (2016). What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?. Current Diabetes Reports. 16(10). 94–94. 2 indexed citations

16.

Xu, Beibei, Dragana Lovre, & Franck Mauvais‐Jarvis. (2015). Effect of selective estrogen receptor modulators on metabolic homeostasis. Biochimie. 124. 92–97. 34 indexed citations

17.

Lovre, Dragana & Vivian Fonseca. (2014). Benefits of timely basal insulin control in patients with type 2 diabetes. Journal of Diabetes and its Complications. 29(2). 295–301. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact